Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering.
George
Sabu J
SJ
Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102-1192, USA.
Dhond
Abhay J
AJ
Alderson
Skip M
SM
Ezekowitz
Michael D
MD
D000328:Adult; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D019821:Simvastatin / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D016896:Treatment Outcome
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D019821:Simvastatin